With One Manufacturer and Little Money to Be Made, Supplies of a Critical Cancer Drug Are Dwindling

February 20, 2019

(STAT News) – It wasn’t just one doctor’s office. There’s a critical national shortage of BCG, a biologic drug that has been used for decades and that is a remarkably effective medicine. Many smaller clinics have already run out of the lifesaving drug, and larger hospitals — including New York’s Memorial Sloan Kettering Cancer Center, where Field is being treated — have changed their policies on distributing BCG to prioritize newly diagnosed patients with active cancers.

Recommended Reading